Dr Jason Alcorn

Go Back

Nurse Consultant

  • Mid Yorkshire Hospitals NHS Trust
  • location United Kingdom

Jason Alcorn is the Nurse Consultant for Uro-oncology and Andrology at the Mid Yorkshire Hospitals NHS Trust.  He has worked at the Trust for 20 years. The Mid Yorkshire Hospitals NHS Trust is a specialist cancer centre for urological cancers. Jason started in the nursing profession after a career in the military.  After completing a Bachelor’s degree developing student nurse resources, he then studied for a Master’s degree seeking to understand registered nurse understanding of delegation to healthcare assistants.  This led to him being a fellow of the higher education academy and a registered teacher.  He then studied for a professional doctorate seeking to understand why patients withdraw early from Bacillus Calmette-Guerin treatment for urothelial cancer. Jason has presented at several national and international conferences, as well as running workshops locally and in the Middle East on behalf of EAUN, and he has also published several articles from his research activity.  He is an active board member of the European Association of Urological Nurses (EAUN) and his responsibilities on the board include education, accreditation and endorsement. __________________________

Dr Jason Alcorn has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Programmes developed by Dr Jason Alcorn

Oncology 
Prostate Cancer Update from ASCO GU, ASCO and EAUN 2022 – 1

Prostate Cancer Update from ASCO GU, ASCO and EAUN 2022

Experts
Dr Jason Alcorn, Jennifer Sutton
  • download Downloadable
    Resources
  • clock 25 MIN
  • calendar Jul 2022

Educational programme supported by an Independent Educational Grant from Bayer
podcast Podcast

Episode

3

of 3

episode
Oncology 
PARP inhibitors in prostate cancer: Management of adverse events and the importance of communication with patients (Episode 3 of 3)

In the third episode of this podcast series on PARP inhibitors in prostate cancer, Dr Jason Alcorn and Dr Alicia Morgans discuss the management of adverse events and the importance of communication with patients in prostate cancer.

Experts
Assoc. Prof. Alicia Morgans, Dr Jason Alcorn
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Jan 2022

Episode

3

of 3

episode
Oncology 
Shared decision-making between nmCRPC patients and the healthcare team (Part 3 of 3)

Dr. Jason Alcorn covers steps 4 and 5 of the GUIDE Communication Framework, explaining how to direct the patient and carer to additional support and the importance of empowering the patient.

Experts
Dr Jason Alcorn
  • download Downloadable
    Resources
  • clock 2 MIN
  • calendar Nov 2021